Tushar Misra

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alejandra Carvajal, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Tushar Misra

Form 4 holding SVP, Chief Manuf. Officer

Mersana Therapeutics, Inc.

Security class
Restricted Stock Unit
Shares / value
41,667
Estimated value
$112,918
Report date
15 Jan 2024
Price
$2.71
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, Chief Manuf. Officer

Mersana Therapeutics, Inc.

Security class
Common Stock
Shares / value
17,966
Estimated value
$48,688
Report date
16 Jan 2024
Price
$2.71
Ownership
Direct
Form 4 holding SVP, Chief Manuf. Officer

Mersana Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
187,500
Estimated value
Report date
15 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Tushar Misra

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .